
North America Minor Cannabinoids Market Databank
Description
North America Minor Cannabinoids Market Databank
The Minor Cannabinoids market was valued at $7,230.0 Million in 2020, and is projected to reach $13,813.2 Million by 2029 growing at a CAGR of 7.51% from 2021 to 2029. Cannabigerol (CBG) segment is expected to be the highest contributor to this market, with $2,174.2 Million in 2020, and is anticipated to reach $4,198.5 Million by 2029, registering a CAGR of 7.64%. Cannabigerolic acid (CBGA) segment is anticipated to reach $1,080.2 Million by 2029 with the highest CAGR of 7.70%. Cannabigerol (CBG) and Cannabichromene (CBC) segments collectively expected to account for about 56.6% share of the Minor Cannabinoids market in 2020, with the former constituting around 30.1% share. Cannabigerolic acid (CBGA) and Cannabigerol (CBG) segments are expected to witness significant growth rates at a CAGR of 7.70% and 7.64% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 37.8% in the overall Minor Cannabinoids market in 2020, and is anticipated to reach 38.2% by 2029.
The report provides market intelligence on various market segments and geography, including market size and forecast information. Its primary goals are to deliver a thorough global market intelligence report by providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding of the market in each region. In addition, we carried out extensive primary research by conducting interviews with key executives in the industry. These interviews helped us to fill any data gaps identified during the secondary research. We used various secondary sources such as encyclopedias, directories, and databases to gather relevant information for this extensive techno-commercial study. We interviewed selected experts from manufacturers and suppliers to obtain and verify critical information, as well as to assess future prospects. The research team evaluated the reliability of the obtained information before using it. In some cases, a combination of multiple sources was used. Sprout Intelligence conducted an in-depth analysis of the market segmentation, which is a crucial component of our market intelligence reports.
The Minor Cannabinoids market was valued at $7,230.0 Million in 2020, and is projected to reach $13,813.2 Million by 2029 growing at a CAGR of 7.51% from 2021 to 2029. Cannabigerol (CBG) segment is expected to be the highest contributor to this market, with $2,174.2 Million in 2020, and is anticipated to reach $4,198.5 Million by 2029, registering a CAGR of 7.64%. Cannabigerolic acid (CBGA) segment is anticipated to reach $1,080.2 Million by 2029 with the highest CAGR of 7.70%. Cannabigerol (CBG) and Cannabichromene (CBC) segments collectively expected to account for about 56.6% share of the Minor Cannabinoids market in 2020, with the former constituting around 30.1% share. Cannabigerolic acid (CBGA) and Cannabigerol (CBG) segments are expected to witness significant growth rates at a CAGR of 7.70% and 7.64% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 37.8% in the overall Minor Cannabinoids market in 2020, and is anticipated to reach 38.2% by 2029.
The report provides market intelligence on various market segments and geography, including market size and forecast information. Its primary goals are to deliver a thorough global market intelligence report by providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding of the market in each region. In addition, we carried out extensive primary research by conducting interviews with key executives in the industry. These interviews helped us to fill any data gaps identified during the secondary research. We used various secondary sources such as encyclopedias, directories, and databases to gather relevant information for this extensive techno-commercial study. We interviewed selected experts from manufacturers and suppliers to obtain and verify critical information, as well as to assess future prospects. The research team evaluated the reliability of the obtained information before using it. In some cases, a combination of multiple sources was used. Sprout Intelligence conducted an in-depth analysis of the market segmentation, which is a crucial component of our market intelligence reports.
Table of Contents
85 Pages
- 1. GLOBAL MINOR CANNABINOIDS MARKET, BY PRODUCT
- 1.1. OVERVIEW
- 1.2. CANNABIGEROL (CBG)
- 1.2.1 CANNABIGEROL (CBG) MARKET, BY REGION
- 1.2.1.1 North America Cannabigerol (CBG) Market, By Country
- 1.2.1.2 Europe Cannabigerol (CBG) Market, By Country
- 1.2.1.3 Asia-Pacific Cannabigerol (CBG) Market, By Country
- 1.2.1.4 Rest of World Cannabigerol (CBG) Market, By Country
- 1.3. CANNABICHROMENE (CBC)
- 1.3.1 CANNABICHROMENE (CBC) MARKET, BY REGION
- 1.3.1.1 North America Cannabichromene (CBC) Market, By Country
- 1.3.1.2 Europe Cannabichromene (CBC) Market, By Country
- 1.3.1.3 Asia-Pacific Cannabichromene (CBC) Market, By Country
- 1.3.1.4 Rest of World Cannabichromene (CBC) Market, By Country
- 1.4. CANNABINOL (CBN)
- 1.4.1 CANNABINOL (CBN) MARKET, BY REGION
- 1.4.1.1 North America Cannabinol (CBN) Market, By Country
- 1.4.1.2 Europe Cannabinol (CBN) Market, By Country
- 1.4.1.3 Asia-Pacific Cannabinol (CBN) Market, By Country
- 1.4.1.4 Rest of World Cannabinol (CBN) Market, By Country
- 1.5. TETRAHYDROCANNABIVARIN (THCV)
- 1.5.1 TETRAHYDROCANNABIVARIN (THCV) MARKET, BY REGION
- 1.5.1.1 North America Tetrahydrocannabivarin (THCV) Market, By Country
- 1.5.1.2 Europe Tetrahydrocannabivarin (THCV) Market, By Country
- 1.5.1.3 Asia-Pacific Tetrahydrocannabivarin (THCV) Market, By Country
- 1.5.1.4 Rest of World Tetrahydrocannabivarin (THCV) Market, By Country
- 1.6. CANNABIGEROLIC ACID (CBGA)
- 1.6.1 CANNABIGEROLIC ACID (CBGA) MARKET, BY REGION
- 1.6.1.1 North America Cannabigerolic acid (CBGA) Market, By Country
- 1.6.1.2 Europe Cannabigerolic acid (CBGA) Market, By Country
- 1.6.1.3 Asia-Pacific Cannabigerolic acid (CBGA) Market, By Country
- 1.6.1.4 Rest of World Cannabigerolic acid (CBGA) Market, By Country
- 1.7. OTHER PRODUCTS
- 1.7.1 OTHER PRODUCTS MARKET, BY REGION
- 1.7.1.1 North America Other Products Market, By Country
- 1.7.1.2 Europe Other Products Market, By Country
- 1.7.1.3 Asia-Pacific Other Products Market, By Country
- 1.7.1.4 Rest of World Other Products Market, By Country
- 2. GLOBAL MINOR CANNABINOIDS MARKET, BY APPLICATION
- 2.1. OVERVIEW
- 2.2. INFLAMMATION
- 2.2.1 INFLAMMATION MARKET, BY REGION
- 2.2.1.1 North America Inflammation Market, By Country
- 2.2.1.2 Europe Inflammation Market, By Country
- 2.2.1.3 Asia-Pacific Inflammation Market, By Country
- 2.2.1.4 Rest of World Inflammation Market, By Country
- 2.3. PAIN MANAGEMENT
- 2.3.1 PAIN MANAGEMENT MARKET, BY REGION
- 2.3.1.1 North America Pain Management Market, By Country
- 2.3.1.2 Europe Pain Management Market, By Country
- 2.3.1.3 Asia-Pacific Pain Management Market, By Country
- 2.3.1.4 Rest of World Pain Management Market, By Country
- 2.4. NEUROLOGICAL DISORDERS
- 2.4.1 NEUROLOGICAL DISORDERS MARKET, BY REGION
- 2.4.1.1 North America Neurological Disorders Market, By Country
- 2.4.1.2 Europe Neurological Disorders Market, By Country
- 2.4.1.3 Asia-Pacific Neurological Disorders Market, By Country
- 2.4.1.4 Rest of World Neurological Disorders Market, By Country
- 2.5. CANCER
- 2.5.1 CANCER MARKET, BY REGION
- 2.5.1.1 North America Cancer Market, By Country
- 2.5.1.2 Europe Cancer Market, By Country
- 2.5.1.3 Asia-Pacific Cancer Market, By Country
- 2.5.1.4 Rest of World Cancer Market, By Country
- 2.6. OTHER APPLICATIONS
- 2.6.1 OTHER APPLICATIONS MARKET, BY REGION
- 2.6.1.1 North America Other Applications Market, By Country
- 2.6.1.2 Europe Other Applications Market, By Country
- 2.6.1.3 Asia-Pacific Other Applications Market, By Country
- 2.6.1.4 Rest of World Other Applications Market, By Country
- 3. GLOBAL MINOR CANNABINOIDS MARKET, BY REGION
- 3.1. OVERVIEW
- 3.2. NORTH AMERICA
- 3.2.1 NORTH AMERICA MINOR CANNABINOIDS MARKET, BY PRODUCT
- 3.2.2 NORTH AMERICA MINOR CANNABINOIDS MARKET, BY APPLICATION
- 3.2.3 NORTH AMERICA MINOR CANNABINOIDS MARKET, BY COUNTRY
- 3.2.3.1 U.S.
- 3.2.3.1.1 U.S. Minor Cannabinoids Market, By Product
- 3.2.3.1.2 U.S. Minor Cannabinoids Market, By Application
- 3.2.3.2 Canada
- 3.2.3.2.1 Canada Minor Cannabinoids Market, By Product
- 3.2.3.2.2 Canada Minor Cannabinoids Market, By Application
- 3.2.3.3 Mexico
- 3.2.3.3.1 Mexico Minor Cannabinoids Market, By Product
- 3.2.3.3.2 Mexico Minor Cannabinoids Market, By Application
- TABLE 1. GLOBAL MINOR CANNABINOIDS MARKET VALUE, BY PRODUCT , 2020-2029, MILLION USD
- TABLE 2. CANNABIGEROL (CBG) MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 3. NORTH AMERICA CANNABIGEROL (CBG) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 4. EUROPE CANNABIGEROL (CBG) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 5. ASIA-PACIFIC CANNABIGEROL (CBG) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 6. REST OF WORLD CANNABIGEROL (CBG) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 7. CANNABICHROMENE (CBC) MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 8. NORTH AMERICA CANNABICHROMENE (CBC) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 9. EUROPE CANNABICHROMENE (CBC) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 10. ASIA-PACIFIC CANNABICHROMENE (CBC) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 11. REST OF WORLD CANNABICHROMENE (CBC) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 12. CANNABINOL (CBN) MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 13. NORTH AMERICA CANNABINOL (CBN) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 14. EUROPE CANNABINOL (CBN) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 15. ASIA-PACIFIC CANNABINOL (CBN) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 16. REST OF WORLD CANNABINOL (CBN) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 17. TETRAHYDROCANNABIVARIN (THCV) MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 18. NORTH AMERICA TETRAHYDROCANNABIVARIN (THCV) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 19. EUROPE TETRAHYDROCANNABIVARIN (THCV) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 20. ASIA-PACIFIC TETRAHYDROCANNABIVARIN (THCV) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 21. REST OF WORLD TETRAHYDROCANNABIVARIN (THCV) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 22. CANNABIGEROLIC ACID (CBGA) MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 23. NORTH AMERICA CANNABIGEROLIC ACID (CBGA) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 24. EUROPE CANNABIGEROLIC ACID (CBGA) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 25. ASIA-PACIFIC CANNABIGEROLIC ACID (CBGA) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 26. REST OF WORLD CANNABIGEROLIC ACID (CBGA) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 27. OTHER PRODUCTS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 28. NORTH AMERICA OTHER PRODUCTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 29. EUROPE OTHER PRODUCTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 30. ASIA-PACIFIC OTHER PRODUCTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 31. REST OF WORLD OTHER PRODUCTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 32. GLOBAL MINOR CANNABINOIDS MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
- TABLE 33. INFLAMMATION MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 34. NORTH AMERICA INFLAMMATION MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 35. EUROPE INFLAMMATION MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 36. ASIA-PACIFIC INFLAMMATION MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 37. REST OF WORLD INFLAMMATION MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 38. PAIN MANAGEMENT MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 39. NORTH AMERICA PAIN MANAGEMENT MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 40. EUROPE PAIN MANAGEMENT MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 41. ASIA-PACIFIC PAIN MANAGEMENT MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 42. REST OF WORLD PAIN MANAGEMENT MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 43. NEUROLOGICAL DISORDERS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 44. NORTH AMERICA NEUROLOGICAL DISORDERS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 45. EUROPE NEUROLOGICAL DISORDERS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 46. ASIA-PACIFIC NEUROLOGICAL DISORDERS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 47. REST OF WORLD NEUROLOGICAL DISORDERS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 48. CANCER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 49. NORTH AMERICA CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 50. EUROPE CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 51. ASIA-PACIFIC CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 52. REST OF WORLD CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 53. OTHER APPLICATIONS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 54. NORTH AMERICA OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 55. EUROPE OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 56. ASIA-PACIFIC OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 57. REST OF WORLD OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 58. GLOBAL MINOR CANNABINOIDS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 59. NORTH AMERICA MINOR CANNABINOIDS MARKET VALUE, BY PRODUCT , 2020-2029, MILLION USD
- TABLE 60. NORTH AMERICA MINOR CANNABINOIDS MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
- TABLE 61. NORTH AMERICA MINOR CANNABINOIDS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 62. U.S. MINOR CANNABINOIDS MARKET VALUE, BY PRODUCT , 2020-2029, MILLION USD
- TABLE 63. U.S. MINOR CANNABINOIDS MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
- TABLE 64. CANADA MINOR CANNABINOIDS MARKET VALUE, BY PRODUCT , 2020-2029, MILLION USD
- TABLE 65. CANADA MINOR CANNABINOIDS MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
- TABLE 66. MEXICO MINOR CANNABINOIDS MARKET VALUE, BY PRODUCT , 2020-2029, MILLION USD
- TABLE 67. MEXICO MINOR CANNABINOIDS MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
- TABLE 68. ROW COUNTRIES MINOR CANNABINOIDS MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
- FIGURE 1. GLOBAL MINOR CANNABINOIDS MARKET VALUE, BY PRODUCT , 2020-2029, MILLION USD
- FIGURE 2. CANNABIGEROL (CBG) MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 3. NORTH AMERICA CANNABIGEROL (CBG) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 4. EUROPE CANNABIGEROL (CBG) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 5. ASIA-PACIFIC CANNABIGEROL (CBG) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 6. REST OF WORLD CANNABIGEROL (CBG) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 7. CANNABICHROMENE (CBC) MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 8. NORTH AMERICA CANNABICHROMENE (CBC) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 9. EUROPE CANNABICHROMENE (CBC) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 10. ASIA-PACIFIC CANNABICHROMENE (CBC) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 11. REST OF WORLD CANNABICHROMENE (CBC) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 12. CANNABINOL (CBN) MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 13. NORTH AMERICA CANNABINOL (CBN) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 14. EUROPE CANNABINOL (CBN) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 15. ASIA-PACIFIC CANNABINOL (CBN) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 16. REST OF WORLD CANNABINOL (CBN) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 17. TETRAHYDROCANNABIVARIN (THCV) MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 18. NORTH AMERICA TETRAHYDROCANNABIVARIN (THCV) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 19. EUROPE TETRAHYDROCANNABIVARIN (THCV) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 20. ASIA-PACIFIC TETRAHYDROCANNABIVARIN (THCV) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 21. REST OF WORLD TETRAHYDROCANNABIVARIN (THCV) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 22. CANNABIGEROLIC ACID (CBGA) MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 23. NORTH AMERICA CANNABIGEROLIC ACID (CBGA) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 24. EUROPE CANNABIGEROLIC ACID (CBGA) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 25. ASIA-PACIFIC CANNABIGEROLIC ACID (CBGA) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 26. REST OF WORLD CANNABIGEROLIC ACID (CBGA) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 27. OTHER PRODUCTS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 28. NORTH AMERICA OTHER PRODUCTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 29. EUROPE OTHER PRODUCTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 30. ASIA-PACIFIC OTHER PRODUCTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 31. REST OF WORLD OTHER PRODUCTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 32. GLOBAL MINOR CANNABINOIDS MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
- FIGURE 33. INFLAMMATION MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 34. NORTH AMERICA INFLAMMATION MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 35. EUROPE INFLAMMATION MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 36. ASIA-PACIFIC INFLAMMATION MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 37. REST OF WORLD INFLAMMATION MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 38. PAIN MANAGEMENT MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 39. NORTH AMERICA PAIN MANAGEMENT MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 40. EUROPE PAIN MANAGEMENT MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 41. ASIA-PACIFIC PAIN MANAGEMENT MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 42. REST OF WORLD PAIN MANAGEMENT MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 43. NEUROLOGICAL DISORDERS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 44. NORTH AMERICA NEUROLOGICAL DISORDERS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 45. EUROPE NEUROLOGICAL DISORDERS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 46. ASIA-PACIFIC NEUROLOGICAL DISORDERS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 47. REST OF WORLD NEUROLOGICAL DISORDERS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 48. CANCER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 49. NORTH AMERICA CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 50. EUROPE CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 51. ASIA-PACIFIC CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 52. REST OF WORLD CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 53. OTHER APPLICATIONS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 54. NORTH AMERICA OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 55. EUROPE OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 56. ASIA-PACIFIC OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 57. REST OF WORLD OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 58. GLOBAL MINOR CANNABINOIDS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 59. NORTH AMERICA MINOR CANNABINOIDS MARKET VALUE, BY PRODUCT , 2020-2029, MILLION USD
- FIGURE 60. NORTH AMERICA MINOR CANNABINOIDS MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
- FIGURE 61. NORTH AMERICA MINOR CANNABINOIDS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 62. U.S. MINOR CANNABINOIDS MARKET VALUE, BY PRODUCT , 2020-2029, MILLION USD
- FIGURE 63. U.S. MINOR CANNABINOIDS MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
- FIGURE 64. CANADA MINOR CANNABINOIDS MARKET VALUE, BY PRODUCT , 2020-2029, MILLION USD
- FIGURE 65. CANADA MINOR CANNABINOIDS MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
- FIGURE 66. MEXICO MINOR CANNABINOIDS MARKET VALUE, BY PRODUCT , 2020-2029, MILLION USD
- FIGURE 67. MEXICO MINOR CANNABINOIDS MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
- FIGURE 68. ROW COUNTRIES MINOR CANNABINOIDS MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.